• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • ITC
    423.35 381.24(%)
  • Trent
    5,106.40 4,058.45(%)
  • Hind. Unilever
    2,339.45 3,034.50(%)
  • Larsen & Toubro
    3,231.30 2,967.65(%)
  • Asian Paints
    2,413.50 2,125.00(%)
  • Ambuja Cements
    544.50 452.90(%)
  • Atul
    6,566.00 8,165.25(%)
  • ACC
    1,930.00 1,778.80(%)
  • Reliance Infra.
    250.50 143.70(%)
  • M & M
    2,831.30 2,001.00(%)
  • Hind.Construct.
    25.51 21.37(%)
  • MRF
    127,450.00 100,500.00(%)
  • Nestle India
    2,387.80 2,115.00(%)
  • PCBL Chemical
    379.15 208.80(%)
  • Hindalco Inds.
    612.90 546.25(%)
  • Force Motors
    8,860.00 6,128.55(%)
  • Indian Hotels Co
    770.20 507.45(%)
  • Kirl.Pneumatic
    1,144.70 790.15(%)
  • Exide Inds.
    367.05 327.95(%)
  • A B B
    5,388.50 4,590.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4704.0
  • ISIN : INE083D01012
107.14 -2 (-1.61%)
  • As on 25 Apr 2025 (EOD)

  • Today’s Low

    104.05

  • Today’s High

    109.57

  • Open

    109.02

  • Perv Close

    108.89

  • 52W Low

    0.00

  • 52W High

    0.00

Key Indicators

  • P/E(TTM)

    16.57

  • Mar.Cap (₹Cr.)

    170.58

  • Div & Yield %

    1.11

  • Book Value(₹)

    67.04

  • Debt-Equity Ratio

    -1.61

  • AGM Date

    25-Apr-2025

  • EPS

    6.49

  • P/E Ratio

    16.57

Financials Ratios

  • Debt-Equity Ratio

    2.03

  • Mar.Cap (₹Cr.)

    170.58

  • RONW (%)

    11.20

  • ROCE (%)

    11.74

Score Board

  • Equity (₹ in Cr.)

    15.92

  • BV (₹)

    67.00

  • Sales( ₹ in Cr.)

    338.54

  • NP (in Cr.)

    10.23

  • NP Var(%)

    68.0

  • Div%

    12.0

  • CPS (₹)

    11.70

  • EPS (₹)

    6.40

  • Traded Value (₹ in Lakhs)

    172.93

  • 52 Week High

    0.00

  • 52 Week Low

    0.00

  • Price BSE

    109.0

  • Price NSE

    109.00

  • Market Capital( in Cr.)

    172.93

  • P/C Ratio

    9.30

  • P/E Ratio

    17.00

  • Price Vs.BV

    6.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 338.54 303.10 280.37 249.31 170.67 223.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 338.54 303.10 280.37 249.31 170.67 223.08
Other Income 3.35 2.19 6.49 2.69 3.63 2.75
Stock Adjustments 1.06 17.90 4.85 -5.13 -3.32 4.41
Total Income 342.95 323.19 291.71 246.87 170.98 230.24
EXPENDITURE :            
Raw Materials 192.80 187.83 171.35 145.45 81.39 121.34
Power and Fuel Cost 7.57 6.87 5.37 4.70 4.68 6.22
Employee Cost 56.11 51.56 44.46 39.62 48.78 48.45
Other Manufacturing Expenses 18.07 20.20 14.64 9.12 7.07 7.35
Selling and Administration Expenses 30.93 26.21 21.64 15.44 17.59 23.05
Miscellaneous Expenses 1.50 1.90 4.35 3.24 0.82 0.59
Employee Benefit Expenses 56.11 51.56 44.46 39.62 48.78 48.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 306.97 294.56 261.82 217.57 160.34 207.00
Operating Profit 35.98 28.62 29.89 29.30 10.64 23.24
Interest 15.42 12.59 10.60 12.25 12.69 12.71
Gross Profit 20.56 16.03 19.29 17.05 -2.05 10.53
Depreciation 8.45 7.48 7.24 7.26 7.03 6.12
Profit Before Tax 12.11 8.55 12.05 9.79 -9.08 4.41
Current Tax 0.76 2.03 5.42 0.38 -0.15 0.95
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.08 0.39 -1.94 0.32 -0.03 -3.30
Reported Net Profit 10.27 6.13 8.58 9.10 -8.90 6.76
Extraordinary Items 0.05 0.03 0.78 0.04 0.00 0.00
Adjusted Net Profit 10.22 6.10 7.80 9.06 -8.90 6.76
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -0.29 -0.29
P & L Balance brought forward 46.94 42.37 35.27 26.18 36.79 31.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.57 1.56 1.48 0.00 1.42 1.42
P & L Balance carried down 55.64 46.94 42.37 35.27 26.17 36.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 12.00 10.00 10.00 10.00 0.00 10.00
Dividend Per Share(Rs) 1.20 1.00 1.00 1.00 0.00 1.00
Earnings Per Share-Unit Curr 6.50 3.90 5.79 6.14 -6.28 4.77
Earnings Per Share(Adj)-Unit Curr 6.50 3.90 5.79 6.14 -6.28 4.77
Book Value 66.81 61.21 58.28 52.88 46.53 54.23
Book Value(Adj)-Unit Curr 66.81 61.21 58.28 52.88 46.53 54.23

Shareholding Pattern

  • Promoter Group

    50.86%

  • Public Share Holding

    49.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 655,187 655,187.00 655,187 655,187
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 655,187 4.12 655,187 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,011,736 12.64 2,011,736 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,430,259 34.11 5,430,259 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,441,995 46.74 7,441,995 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 21,822 0.14 21,822 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 21,822 0.14 21,822 3
2] Non Institution
Bodies Corporate 122,505 0.77 122,004 62
Clearing Members 570 0.00 570 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,987,600 12.48 1,978,100 177
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 368,578 2.32 368,578 262
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,411,650 8.87 1,411,650 21
Individuals holding nominal share capital up to Rs. 1 lakh 3,761,759 23.63 3,672,324 15,177
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 132,104 0.83 132,104 1
Sub Total 7,801,868 49.00 7,702,432 15,709
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,920,872 100.00 15,821,436 15,723

Company Background

Bal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Bal Pharma Ltd
  • BSE Code : 4704.0
  • ISIN : INE083D01012

  • Incorporation Year

    1987

  • Registered Office

    21 & 22 Bommasandra Indl Area
    Hosur Road, Bangalore,
    Karnataka-560092

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Shailesh Siroya

  • Company Secretary

    Abdul Basith

  • Auditor

    SSJNB & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    TSR Consultants P Ltd
    C-101 1st Floor,
    247 Park Vikhroli W,Lal Bahadur Marg
    Mumbai - Mumbai - 400 083

Bal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bal Pharma 107.51 341.89 338.54 16.57 11.63
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92